Frederick A Moore Selected Research

HDL Lipoproteins

1/2019	LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock.
1/2018	HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock.
1/2018	HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study.
11/2017	Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederick A Moore Research Topics

Disease

54	Sepsis (Septicemia) 03/2022 - 11/2005
49	Wounds and Injuries (Trauma) 10/2021 - 05/2002
36	Critical Illness (Critically Ill) 06/2022 - 09/2002
31	Inflammation (Inflammations) 01/2022 - 04/2004
30	Shock 10/2021 - 05/2002
13	Multiple Organ Failure (MODS) 02/2018 - 05/2003
12	Hemorrhage 01/2021 - 01/2004
12	Intra-Abdominal Hypertension 01/2017 - 12/2002
9	Infections 01/2021 - 05/2006
9	Ischemia 01/2018 - 07/2002
8	Mesenteric Ischemia 06/2022 - 06/2002
8	Anemia 03/2022 - 01/2009
8	Hemorrhagic Shock 10/2021 - 08/2008
8	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 05/2011
8	Edema (Dropsy) 10/2013 - 04/2004
7	Traumatic Shock 10/2014 - 12/2002
6	Pneumonia (Pneumonitis) 01/2018 - 11/2002
6	Reperfusion Injury 01/2010 - 06/2002
5	Hypertension (High Blood Pressure) 03/2007 - 02/2005
4	Malnutrition (Nutritional Deficiencies) 01/2021 - 04/2015
4	Coinfection 12/2020 - 12/2015
4	Hypothermia 10/2010 - 08/2002
4	Lung Injury 10/2010 - 04/2003
3	Multiple Trauma (Multiple Injuries) 10/2021 - 04/2013
3	Abdominal Injuries 02/2019 - 05/2003
3	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2009
3	Peritonitis 01/2018 - 05/2006
3	Appendicitis 01/2018 - 01/2017
3	Neoplasms (Cancer) 04/2017 - 01/2017
3	Necrosis 10/2009 - 11/2005
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 08/2018
2	Pancreatitis 08/2018 - 01/2017
2	Soft Tissue Infections 01/2018 - 06/2014
2	Kidney Diseases (Kidney Disease) 01/2018 - 11/2013
2	Cross Infection (Nosocomial Infection) 10/2017 - 04/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2017 - 02/2009
2	Sarcopenia 04/2017 - 04/2015
2	Cachexia 04/2017 - 04/2015

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 03/2022 - 09/2009
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2011
11	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2002
9	Hemoglobins (Hemoglobin)IBA 03/2022 - 04/2004
8	Anti-Bacterial Agents (Antibiotics)IBA 11/2019 - 12/2010
8	salicylhydroxamic acid (SHAM)IBA 04/2013 - 08/2002
6	Crystalloid SolutionsIBA 01/2017 - 12/2002
5	AlarminsIBA 01/2020 - 10/2017
5	ChemokinesIBA 11/2019 - 10/2010
5	Oxygen (Dioxygen)IBA 04/2009 - 11/2002
4	LipidsIBA 05/2021 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2003
4	HDL LipoproteinsIBA 01/2019 - 11/2017
4	Glucose (Dextrose)FDA LinkGeneric 08/2015 - 07/2002
4	Glutamine (L-Glutamine)FDA Link 03/2005 - 09/2002
3	Erythropoietin FDA Link 03/2022 - 01/2018
3	CholesterolIBA 05/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2010
3	AlbuminsIBA 01/2018 - 01/2014
3	LigandsIBA 01/2018 - 10/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 03/2011 - 01/2004
3	Poloxamer (Poloxamer 407)IBA 01/2010 - 08/2008
3	Saline SolutionIBA 06/2006 - 02/2005
3	Alanine (L-Alanine)FDA Link 05/2004 - 07/2002
3	NF-kappa B (NF-kB)IBA 11/2003 - 08/2002
2	InterleukinsIBA 10/2021 - 01/2019
2	C-Reactive ProteinIBA 10/2021 - 10/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 05/2021 - 01/2021
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2021 - 01/2021
2	Small Cytoplasmic RNAIBA 01/2021 - 01/2021
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2019
2	IronIBA 01/2019 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2007
2	Fish OilsIBA 01/2019 - 08/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2019 - 10/2017
2	CatecholaminesIBA 10/2018 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 12/2015
2	Insulin (Novolin)FDA Link 01/2018 - 04/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2014
2	EnzymesIBA 01/2018 - 04/2004

Therapy/Procedure

49	Resuscitation 01/2020 - 05/2002
22	Critical Care (Surgical Intensive Care) 06/2022 - 03/2007
16	Therapeutics 06/2022 - 03/2008
11	Laparotomy 02/2019 - 08/2002
9	Length of Stay 07/2021 - 04/2003
6	Enteral Nutrition (Feeding, Tube) 06/2022 - 11/2002
6	Mechanical Ventilators (Ventilator) 01/2021 - 04/2003
5	Blood Transfusion (Blood Transfusions) 01/2021 - 05/2009
5	Ligation 01/2021 - 11/2005
4	Punctures 01/2021 - 01/2014
4	Artificial Respiration (Mechanical Ventilation) 01/2017 - 12/2006
3	Nutritional Support (Artificial Feeding) 01/2021 - 09/2004
3	Erythrocyte Transfusion 01/2018 - 06/2003
3	Appendectomy 01/2018 - 01/2017
3	Catheters 11/2009 - 06/2003
2	Long-Term Care 01/2020 - 12/2017
2	Analgesia 11/2019 - 04/2003
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2015
2	Thoracotomy 01/2018 - 12/2012
2	Herniorrhaphy 01/2018 - 01/2017